Search

Search Constraints

You searched for: Author/Creator Sullivan, Danielle

Search Results

2. Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial. Issue 4 (April 2018)

3. Safety and pharmacokinetics of veliparib extended‐release in patients with advanced solid tumors: a phase I study. (7th May 2018)